UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management

Urology (Ridgewood, N.J.), 2011-07, Vol.78 (1), p.82-86

2011

Volltextzugriff (PDF)

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

Cancer, 2010-06, Vol.116 (12), p.2967-2973

2010

Volltextzugriff (PDF)

ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol

BMJ open, 2024-06, Vol.14 (6), p.e076763

2024

Volltextzugriff (PDF)

Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model

Neoplasia (New York, N.Y.), 2010-05, Vol.12 (5), p.388,IN3-396,IN4

2010

Volltextzugriff (PDF)

Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells

Cell cycle (Georgetown, Tex.), 2012-10, Vol.11 (19), p.3649-3655

2012

Volltextzugriff (PDF)

Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials

Urologic oncology, 2024-08, Vol.42 (8), p.223-228

2024

Volltextzugriff (PDF)

Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer

Translational andrology and urology, 2024-08, Vol.13 (8), p.1349-1363

2024

Volltextzugriff (PDF)

MP49-20 SYNERGISTIC EFFECT OF TARGETED COMBINATION THERAPY IN BLADDER CANCER MODEL USING HSP90 INHIBITORS

The Journal of urology, 2015-04, Vol.193 (4), p.e610-e610

2015

Volltextzugriff (PDF)

MP83-09 TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) POTENTIATES THE EFFECT OF BACILLUS CALMETTE-GUÉRIN (BCG) IN UROTHELIAL CARCINOMA MODEL

The Journal of urology, 2016-04, Vol.195 (4), p.e1084-e1084

2016

Volltextzugriff (PDF)

CD117⁺ cells in the circulation are predictive of advanced prostate cancer

Oncotarget, 2015-01, Vol.6 (3), p.1889-1897

2015

Volltextzugriff (PDF)

Optimizing Orthotopic Bladder Tumor Implantation in a Syngeneic Mouse Model

The Journal of urology, 2009-12, Vol.182 (6), p.2926-2931

2009

Volltextzugriff (PDF)

Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action

Clinical Immunology, Endocrine & Metabolic Drugs, 2016-10, Vol.3 (1), p.31-38

2016

Volltextzugriff (PDF)

585 HEREDITARY PAPILLARY RENAL CELL CARCINOMA: A 20-YEAR EXPERIENCE IN MANAGEMENT OF A UNIQUE HEREDITARY CANCER SYNDROME

The Journal of urology, 2012-04, Vol.187 (4), p.e239-e239

2012

Volltextzugriff (PDF)

TARGETED CONTRAST ULTRASOUND DETECTION AND QUANTIFICATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS IN BLADDER CANCER

The Journal of urology, 2009, Vol.181 (4), p.305-305

2009

Volltextzugriff (PDF)

ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL

Urologic oncology, 2024-03, Vol.42, p.S54-S54

2024

Volltextzugriff (PDF)

Abstract 3796: Synergistic effect of targeted combination therapy in bladder cancer model using HSP90 inhibitors

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3796-3796

2015

Volltextzugriff (PDF)

Dysregulation of estrogen receptor Β pathway as a mechanism of bacillus calmette-guérin resistance in bladder cancer

Urologic oncology, 2017-10, Vol.35 (10), p.619-619

2017

Volltextzugriff (PDF)

SECOND STAGE URETHROPLASTY AUGMENTED BY ORAL MUCOSA: AN ALTERNATIVE TO REVISION OF THE FIRST STAGE

The Journal of urology, 2008, Vol.179 (4), p.13-13

2008

Volltextzugriff (PDF)

Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model12

Neoplasia (New York, N.Y.), 2010-05, Vol.12 (5), p.388-396

2010

Volltextzugriff (PDF)

Nephroureterectomy

Atlas of Laparoscopic and Robotic Urologic Surgery, 2017, p.120-131

Third Edition, 2017

Volltextzugriff (PDF)

IS THERE A ROLE FOR CYTOLOGY IN THE DIAGNOSIS OF UPPER TRACT UROTHELIAL CANCER?

The Journal of urology, 2009, Vol.181 (4), p.132-132

2009

Volltextzugriff (PDF)

NANOTECHNOLOGY-MEDIATED DELIVERY OF CHEMOTHERAPY IN THE TREATMENT OF UROTHELIAL CARCINOMA

The Journal of urology, 2009, Vol.181 (4), p.408-409

2009

Volltextzugriff (PDF)

DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA AND IMPLICATIONS FOR THE ADMINISTRATION OF CISPLATIN-BASED CHEMOTHERAPY

The Journal of urology, 2009, Vol.181 (4), p.136-137

2009

Volltextzugriff (PDF)

DOES THE CHOICE OF TECHNIQUE FOR MANAGEMENT OF THE BLADDER CUFF AFFECT ONCOLOGIC OUTCOMES OF NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER?

The Journal of urology, 2009, Vol.181 (4), p.133-134

2009

Volltextzugriff (PDF)

QUANTIFICATION OF SUNITINIB'S ANTITUMOR EFFECTS IN A LOCALIZED ORTHOTOPIC BLADDER CANCER MODEL

The Journal of urology, 2009, Vol.181 (4), p.409-409

2009

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(27)
Buchkapitel
(2)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Urology
(15)
Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Humans
(7)
Male
(6)
Female
(4)
Oncology
(4)
Urology & Nephrology
(4)
Animals
(3)
Biological And Medical Sciences
(3)
Cancer
(3)
Medical Sciences
(3)
Mice
(3)
Nephrology. Urinary Tract Diseases
(3)
Surveillance
(3)
Tumors
(3)
Urinary System Involvement In Other Diseases. Miscellaneous
(3)
Aged
(2)
Biomarkers, Tumor - Blood
(2)
Cell Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(12)
Urologic Oncology
(3)
Neoplasia
(2)
Bmj Open
(1)
Cancer
(1)
Cancer Research
(1)
Cell Cycle
(1)
Cell Cycle/cell Cycle
(1)
Clinical Immunology, Endocrine & Metabolic Drugs
(1)
Nature Communications
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol

Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model

Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells

Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials

Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer

MP49-20 SYNERGISTIC EFFECT OF TARGETED COMBINATION THERAPY IN BLADDER CANCER MODEL USING HSP90 INHIBITORS

MP83-09 TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) POTENTIATES THE EFFECT OF BACILLUS CALMETTE-GUÉRIN (BCG) IN UROTHELIAL CARCINOMA MODEL

CD117⁺ cells in the circulation are predictive of advanced prostate cancer

Optimizing Orthotopic Bladder Tumor Implantation in a Syngeneic Mouse Model

Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action

585 HEREDITARY PAPILLARY RENAL CELL CARCINOMA: A 20-YEAR EXPERIENCE IN MANAGEMENT OF A UNIQUE HEREDITARY CANCER SYNDROME

TARGETED CONTRAST ULTRASOUND DETECTION AND QUANTIFICATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS IN BLADDER CANCER

ERAS FOR AMBULATORY TURBT: ENHANCING BLADDER CANCER CARE (EMBRACE) RANDOMIZED CONTROLLED TRIAL

Abstract 3796: Synergistic effect of targeted combination therapy in bladder cancer model using HSP90 inhibitors

Dysregulation of estrogen receptor Β pathway as a mechanism of bacillus calmette-guérin resistance in bladder cancer

SECOND STAGE URETHROPLASTY AUGMENTED BY ORAL MUCOSA: AN ALTERNATIVE TO REVISION OF THE FIRST STAGE

Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model12

Nephroureterectomy

IS THERE A ROLE FOR CYTOLOGY IN THE DIAGNOSIS OF UPPER TRACT UROTHELIAL CANCER?

NANOTECHNOLOGY-MEDIATED DELIVERY OF CHEMOTHERAPY IN THE TREATMENT OF UROTHELIAL CARCINOMA

DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA AND IMPLICATIONS FOR THE ADMINISTRATION OF CISPLATIN-BASED CHEMOTHERAPY

DOES THE CHOICE OF TECHNIQUE FOR MANAGEMENT OF THE BLADDER CUFF AFFECT ONCOLOGIC OUTCOMES OF NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER?

QUANTIFICATION OF SUNITINIB'S ANTITUMOR EFFECTS IN A LOCALIZED ORTHOTOPIC BLADDER CANCER MODEL

Suchergebnisse filtern